People | April 06, 2026
Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio
With more than two decades of experience, he brings deep expertise in sales, marketing, business transformation, and strategic leadership
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
The company said the increase—up to 20%—takes effect immediately, or as current contracts allow
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment
Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
The agreement will combine Biocytogen’s cutting-edge fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive drug development
Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors
Subscribe To Our Newsletter & Stay Updated
